𝛼SK or Search

ENTITY

Maze Therapeutics (MAZE US)

12

Analysis

Health Care • United States

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic diseases, including obesity.

more

Refresh

Exchange Announcement • 12 Aug 2026 04:48

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 12 Aug 2026 04:45

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 11 Jun 2026 04:15

Current Report (Form 8-K | Period ending 2026-06-08)

Exchange Announcement • 23 May 2026 05:24

Current Report (Form 8-K | Period ending 2026-05-18)

Exchange Announcement • 13 May 2026 04:11

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x